Using Sleeping Beauty to Fight Colorectal Cancer Spread to the Liver
Author Information
Author(s): Belur Lalitha R, Podetz-Pedersen Kelly M, Sorenson Brent S, Hsu Alice H, Parker Josh B, Carlson Cathy S, Saltzman Daniel A, Ramakrishnan S, McIvor R Scott
Primary Institution: University of Minnesota
Hypothesis
Can an antiangiogenic gene transfer approach using the Sleeping Beauty transposon system inhibit growth of colorectal tumors metastatic to the liver?
Conclusion
The study found that using antiangiogenic transposons can reduce liver metastases from colorectal cancer.
Supporting Evidence
- Animals treated with the antiangiogenic transposon showed significantly lower liver weights compared to untreated controls.
- Histological analysis revealed lower tumor cell proliferation in treated animals.
- Survival was significantly extended in mice treated with both transposon and transposase.
Takeaway
Scientists are trying to stop cancer from spreading to the liver by using special genes that can block blood vessel growth in tumors.
Methodology
Mice with liver tumors were injected with a plasmid containing an antiangiogenic gene and a transposase, and tumor growth was measured.
Limitations
The study did not achieve complete tumor eradication in any treated group.
Participant Demographics
Female Balb/c mice, 6-8 weeks old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website